Sorimachi Takatoshi, Ito Yasushi, Morita Kenichi, Jimbo Yasushi, Nishino Kazuhiko, Sasaki Osamu, Koike Tetsuo, Kumagai Takashi, Fujii Yukihiko
Department of Neurosurgery, Brain Research Institute, University of Niigata, Japan.
Neurol Res. 2012 Nov;34(9):864-70. doi: 10.1179/1743132812Y.0000000084. Epub 2012 Aug 9.
The selection of therapeutic modalities, including endovascular coil embolization and surgical clipping, for management of unruptured paraclinoid aneurysms, remains controversial. Detailed long-term outcome data for endovascular coil embolization of unruptured paraclinoid aneurysms are still lacking. Thus, we evaluated the safety and efficacy of coil embolization of unruptured paraclinoid aneurysms.
From January 1998 to July 2010, 138 patients underwent endovascular coiling for 140 unruptured paraclinoid aneurysms. Their medical records and radiologic images were reviewed retrospectively.
Complications occurred in 5·7% of 140 procedures and the morbidity rate was 0·7%. Of the 140 unruptured paraclinoid aneurysms, a total of 111 aneurysms underwent follow-up imaging evaluation at 2 years or more, or showing reopening on imaging studies within 2 years (65·6±37·2 months). Multivariate analysis revealed two predictors for reopening of the aneurysms: a maximum diameter of aneurysms and a dome/neck ratio of aneurysms (P<0·05). Reopening rates of aneurysms with maximum sizes of <8, 8-10, and >10 mm were 1%, 25%, and 75%, respectively. Reopening rates were significantly different among the three groups (P<0·05). In aneurysms with a maximum diameter of 8-10 mm, there was a significant difference of dome/neck ratios between the presence and absence of reopened aneurysms (P<0·05).
The results indicate that endovascular coil embolization is a safe and effective treatment modality in selected patients with unruptured paraclinoid aneurysms. Consideration of the aneurysm size and the dome/neck ratio could assist in the selection of therapeutic modalities for these aneurysms.
对于未破裂的床突旁动脉瘤,包括血管内弹簧圈栓塞和外科夹闭在内的治疗方式的选择仍存在争议。目前仍缺乏关于未破裂床突旁动脉瘤血管内弹簧圈栓塞详细的长期结果数据。因此,我们评估了未破裂床突旁动脉瘤弹簧圈栓塞的安全性和有效性。
从1998年1月至2010年7月,138例患者因140个未破裂床突旁动脉瘤接受了血管内弹簧圈栓塞治疗。对他们的病历和影像学资料进行了回顾性分析。
140例手术中有5.7%发生并发症,发病率为0.7%。在140个未破裂的床突旁动脉瘤中,共有111个动脉瘤在2年或更长时间后接受了随访影像学评估,或在2年内影像学检查显示再通(65.6±37.2个月)。多因素分析显示了动脉瘤再通的两个预测因素:动脉瘤的最大直径和动脉瘤的瘤顶/瘤颈比(P<0.05)。最大尺寸<8mm、8-10mm和>10mm的动脉瘤再通率分别为1%、25%和75%。三组之间的再通率有显著差异(P<0.05)。在最大直径为8-10mm的动脉瘤中,再通和未再通的动脉瘤之间瘤顶/瘤颈比有显著差异(P<0.05)。
结果表明,血管内弹簧圈栓塞对于部分未破裂床突旁动脉瘤患者是一种安全有效的治疗方式。考虑动脉瘤大小和瘤顶/瘤颈比有助于为这些动脉瘤选择治疗方式。